A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)

Clinical trial NCT02492763 · TERMINATED

Trial details

NCT number: NCT02492763
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2015-07-27
Primary completion: 2017-04-18
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.